12503 Results

People

  1. Brennan
    Brennan
  2. Gonen
    Gonen
  3. Jarnagin
    Jarnagin
  4. Ladanyi
    Ladanyi
  5. Shah
    Shah
  6. Abu-Rustum
    Abu-Rustum
  7. Morrow
    Morrow
  8. Antonescu
    Antonescu
  9. Offit
    Offit
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (4167)
  2. Surgery (3250)
  3. Solid Tumor Oncology Division (2498)
  4. Survivorship Research (2334)
  5. GSK Faculty (1766)
  6. Population Sciences Research Program (1576)
  7. Epidemiology and Biostatistics (1518)
  8. Department of Pathology and Laboratory Medicine (1440)
  9. Sloan Kettering Institute Postdocs (1351)
  10. Sloan Kettering Institute Faculty (1300)
  1. "female"
Formats
  1. Journal Article (11577)
  2. Review (298)
  3. Conference Paper (206)
  4. Research Letter (161)
  5. Editorial (121)
  6. Correspondence (43)
  7. Guidelines (41)
  8. Miscellaneous (40)
  9. Meeting Abstract (14)
  10. Book Section (1)
  11. Book Whole (1)
Groups
  1. Department of Medicine (4167)
  2. Surgery (3250)
  3. Solid Tumor Oncology Division (2498)
  4. Survivorship Research (2334)
  5. GSK Faculty (1766)
  6. Population Sciences Research Program (1576)

More Groups

People
  1. Murray Brennan (344)
  2. Mithat Gonen (171)
  3. William Jarnagin (164)
  4. Marc Ladanyi (163)
  5. Jatin Shah (158)
  6. Nadeem Abu-Rustum (149)

More People

Years
  1. 2025 (540)
  2. 2024 (1379)
  3. 2023 (871)
  4. 2022 (688)
  5. 2021 (325)
  6. 2020 (652)

More Years

Publications
  1. Cancer (566)
  2. Journal of Clinical Oncology (471)
  3. Annals of Surgical Oncology (371)
  4. Gynecologic Oncology (291)
  5. International Journal of Radiation Oncology, Biology, Physics (229)
  6. Clinical Cancer Research (216)

More Publications

Publishers
  1. Elsevier Inc. (1641)
  2. Springer (1091)
  3. Wiley Blackwell (986)
  4. Lippincott Williams & Wilkins (980)
  5. Elsevier Science, Inc. (747)
  6. Nature Publishing Group (606)

More Publishers

Results (12503)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying baseline rectal MRI features as predictive indicators for local recurrence and metastatic disease in rectal cancer treated with surgical resection and neoadjuvant therapy or surgical resection alone
    Journal Article

    El Homsi, M.; Javed-Tayyab, S.; Charbel, C.; Golia Pernicka, J. S.; Paroder, V.; White, C.; Capanu, M.; Rodriguez, L.; Gangai, N.; Petkovska, I.
    European Journal of Radiology (2025)

    Fulltext@MSK | Save
  • A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer
    Journal Article

    Gouda, M. A.; Voss, M. H.; Tawbi, H.; Gordon, M.; Tykodi, S. S.; Lam, E. T.; Vaishampayan, U.; Tannir, N. M.; Chaves, J.; Nikolinakos, P.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes: Hypogammaglobulinemia after rituximab in children
    Journal Article

    Höppener, S. P. C.; Veldkamp, S. R.; de Groot, M. C. H.; Haitjema, S.; Drylewicz, J.; Boelens, J. J.; Lindemans, C. A.; van Montfrans, J.; van Royen-Kerkhof, A.; Jansen, M. H. A.
    Clinical Immunology Communications (2025)

    Fulltext@MSK | Save
  • Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
    Journal Article

    Yin, Y.; Xu, H.; He, L.; Brown, J. R.; Mato, A. R.; Aittokallio, T.; Skånland, S. S.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Clinical implications of the cancer genome atlas molecular classification system in esophagogastric cancer
    Journal Article

    Walch, H. S.; Borpatragohain, R.; Jee, J.; Chatila, W.; Fong, C.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; Wu, A. J.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of the HIF-2 alpha inhibitor DFF332 in patients with advanced clear-cell renal cell carcinoma
    Journal Article

    Pal, S. K.; Bernard-Tessier, A.; Grell, P.; Gao, X.; Kotecha, R. R.; Picus, J.; de Braud, F.; Takahashi, S.; Wong, A.; Suárez, C.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Phase I trial of selinexor in pediatric recurrent/refractory solid and CNS tumors (ADVL1414): A Children’s Oncology Group phase I consortium trial
    Journal Article

    Green, A. L.; Minard, C. G.; Liu, X.; Safgren, S. L.; Pinkney, K.; Harris, L.; Link, G.; DeSisto, J.; Voss, S.; Nelson, M. D.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Recommended clinical context and patient context data elements for liquid biopsy data submitted to data repositories and data commons
    Guidelines

    Grossman, R. L.; Vinson, J.; Bain, E.; Bisselou, K.; Chandan, S.; Compton, C.; Hu, J.; Johann, D. J.; Jones, F.; Jones, G.; more...
    CTS-Clinical and Translational Science (2025)

    Fulltext@MSK | Save
  • Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer
    Journal Article

    Catozzi, A.; Peiris Pagès, M.; Humphrey, S.; Revill, M.; Morgan, D.; Roebuck, J.; Chen, Y.; Davies-Williams, B.; Brennan, K.; Mukarram Hossain, A. S. M.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save